Related Experiment Video
Updated: Jul 23, 2025

Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System
Published on: January 5, 2024
Fosfomycin resistance mechanisms in Enterobacterales: an increasing threat
Vittoria Mattioni Marchetti1,2,3, Jaroslav Hrabak1,2, Ibrahim Bitar1,2
1Department of Microbiology, Faculty of Medicine, University Hospital in Pilsen, Charles University, Pilsen, Czechia.
Abstract:
Antimicrobial resistance is well-known to be a global health and development threat. Due to the decrease of effective antimicrobials, re-evaluation in clinical practice of old antibiotics, as fosfomycin (FOS), have been necessary. FOS is a phosphonic acid derivate that regained interest in clinical practice for the treatment of complicated infection by multi-drug resistant (MDR) bacteria. Globally, FOS resistant Gram-negative pathogens are raising, affecting the public health, and compromising the use of the antibiotic. In particular, the increased prevalence of FOS resistance (FOSR) profiles among Enterobacterales family is concerning. Decrease in FOS effectiveness can be caused by i) alteration of FOS influx inside bacterial cell or ii) acquiring antimicrobial resistance genes. In this review, we investigate the main components implicated in FOS flow and report specific mutations that affect FOS influx inside bacterial cell and, thus, its effectiveness. FosA enzymes were identified in 1980 from Serratia marcescens but only in recent years the scientific community has started studying their spread. We summarize the global epidemiology of FosA/C2/L1-2 enzymes among Enterobacterales family. To date, 11 different variants of FosA have been reported globally. Among acquired mechanisms, FosA3 is the most spread variant in Enterobacterales, followed by FosA7 and FosA5. Based on recently published studies, we clarify and represent the molecular and genetic composition of fosA/C2 genes enviroment, analyzing the mechanisms by which such genes are slowly transmitting in emerging and high-risk clones, such as E. coli ST69 and ST131, and K. pneumoniae ST11. FOS is indicated as first line option against uncomplicated urinary tract infections and shows remarkable qualities in combination with other antibiotics. A rapid and accurate identification of FOSR type in Enterobacterales is difficult to achieve due to the lack of commercial phenotypic susceptibility tests and of rapid systems for MIC detection.
Insights
Fosfomycin resistance is rising in Gram-negative bacteria, particularly Enterobacterales, due to altered influx and resistance genes like FosA. Identifying resistance is challenging, impacting treatment options.
Area of Science:
- Microbiology
- Infectious Diseases
- Antimicrobial Resistance
Background:
- Antimicrobial resistance (AMR) poses a global health threat, necessitating the re-evaluation of older antibiotics like fosfomycin (FOS).
- Fosfomycin is regaining clinical interest for treating multi-drug resistant (MDR) bacterial infections.
- Rising fosfomycin resistance (FOSR) in Gram-negative pathogens, especially Enterobacterales, compromises its effectiveness.
Purpose of the Study:
- To review the mechanisms of FOS influx into bacterial cells.
- To investigate mutations affecting FOS effectiveness.
- To summarize the global epidemiology of FosA/C2/L1-2 enzymes in Enterobacterales.
Main Methods:
- Literature review of studies on FOS influx mechanisms.
- Analysis of mutations impacting FOS transport and efficacy.
- Epidemiological summary of FosA/C2/L1-2 enzyme variants in Enterobacterales.
Main Results:
- FOS effectiveness is reduced by altered FOS influx or acquired resistance genes.
- Eleven variants of FosA enzymes have been reported globally.
- FosA3 is the most prevalent acquired resistance mechanism in Enterobacterales, followed by FosA7 and FosA5.
- Genes like fosA/C2 are transmitting in high-risk clones (e.g., E. coli ST131, K. pneumoniae ST11).
- Rapid identification of FOSR in Enterobacterales is hindered by a lack of commercial tests.
Conclusions:
- Understanding FOS influx mechanisms and resistance gene spread is crucial for combating AMR.
- Fosfomycin remains valuable, especially in combination therapy, but resistance surveillance is needed.
- Development of rapid diagnostic tools for FOS resistance is essential for effective clinical management.
More Related Videos
08:19Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing
Published on: July 7, 2020
08:58Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes
Published on: March 3, 2023
Related Concept Videos
Development of Antibiotic Resistance
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Gene Regulation in Microbial Communities: Quorum Sensing
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Antibiotic Selection
Biofilms